Analysts have maintained their price target for CRISIL at ₹5,056.50. They cite stable projections for revenue growth, profit margins, and future valuation metrics as factors supporting their unchanged outlook.
What's in the News
- The Board of Directors approved the payment of a third interim dividend of INR 16 per equity share for the financial year ending December 31, 2025. Payment is scheduled for November 6, 2025 (Board Announcement).
- A Board Meeting was held on October 17, 2025, to consider and approve the unaudited consolidated and standalone financial results for the third quarter and nine months ended September 30, 2025, as well as the interim dividend (Board Announcement).
- A Special or Extraordinary Shareholders Meeting took place on October 25, 2025, via postal ballot to consider the appointment of Mr. Dinesh Khara as an independent director and address other matters (Shareholders Meeting Notice).
Valuation Changes
- Consensus Analyst Price Target remains unchanged at ₹5,056.50.
- Discount Rate has fallen slightly from 14.73% to 14.50%.
- Revenue Growth projection is virtually unchanged at 13.02%.
- Net Profit Margin estimate is stable, showing a minor adjustment from 24.39% to 24.39%.
- Future P/E ratio has decreased marginally from 45.50x to 45.22x.
Have other thoughts on CRISIL?
Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.
Create NarrativeDisclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.